Novavax
NVAX
$4.09
Share price
3.54%
Change (1 day)
-46.68%
Change (1 year)
Categories
Novavax (NVAX) Fails to deliver data
Key failure to deliver metrics for Novavax:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $3.57 M
- Last 3 months FTD volume: $39.62 M
- Last year FTD volume: $0.34 B
Failures to deliver for Novavax (NVAX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Novavax (NVAX) - since 2019
Volume in USD (price x number of shares), data since 2019Novavax (NVAX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $39.43 M | -89.9% |
| 2023 | $0.39 B | -2.97% |
| 2022 | $0.40 B | 0.26% |
| 2021 | $0.40 B | 22.77% |
| 2020 | $0.32 B | 531.98% |
| 2019 | $51.73 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.10 B | $0.17 B | 🇬🇧 UK |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $6.44 M | $36.3 M | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.8 M | $3.83 M | 🇺🇸 USA |
 Agenus
AGEN | $3.33 M | $6.35 M | 🇺🇸 USA |
 NanoViricides NNVC | $0.04 M | $0.04 M | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.45 M | $1.95 M | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.74 M | $6.58 M | 🇺🇸 USA |